Evidence map›Paper›PMID 40137979›Full record

ArticleCellular and molecular life sciences : CMLS2025

Microglia regulate myelin clearance and cholesterol metabolism after demyelination via interferon regulatory factor 5.

Alejandro Montilla, Alazne Zabala, Ibai Calvo, Marina Bosch-Juan, Irene Tomé-Velasco, Paloma Mata, Mirjam Koster, Amanda Sierra, Susanne M Kooistra, Federico N Soria and 6 more

Abstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Alejandro MontillaAchucarro Basque Center for Neuroscience, E-48940, Leioa, Spain. alejandro.montilla@ehu.eus.
Alazne ZabalaAchucarro Basque Center for Neuroscience, E-48940, Leioa, Spain.
Ibai CalvoDepartment of Physical Chemistry, Faculty of Sciences, University of the Basque Country UPV/EHU, E-48940, Leioa, Spain.
Marina Bosch-JuanAchucarro Basque Center for Neuroscience, E-48940, Leioa, Spain.
Irene Tomé-VelascoAchucarro Basque Center for Neuroscience, E-48940, Leioa, Spain.
Paloma MataAchucarro Basque Center for Neuroscience, E-48940, Leioa, Spain.
Mirjam KosterDepartment of Biomedical Sciences of Cells and Systems, Section Molecular Neurobiology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Amanda SierraAchucarro Basque Center for Neuroscience, E-48940, Leioa, Spain.
Susanne M KooistraDepartment of Biomedical Sciences of Cells and Systems, Section Molecular Neurobiology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Federico N SoriaAchucarro Basque Center for Neuroscience, E-48940, Leioa, Spain.
Bart J L EggenDepartment of Biomedical Sciences of Cells and Systems, Section Molecular Neurobiology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Olatz FresnedoLipids & Liver Research Group, Department of Physiology, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, E-48940, Leioa, Spain.
José Andrés FernándezDepartment of Physical Chemistry, Faculty of Sciences, University of the Basque Country UPV/EHU, E-48940, Leioa, Spain.
Vanja TepavcevicAchucarro Basque Center for Neuroscience, E-48940, Leioa, Spain.
Carlos MatuteAchucarro Basque Center for Neuroscience, E-48940, Leioa, Spain. carlos.matute@ehu.eus.
María DomercqAchucarro Basque Center for Neuroscience, E-48940, Leioa, Spain. maria.domercq@ehu.eus.ORCID http://orcid.org/0000-0002-4918-9276

Funding

Agencia Nacional de Investigación y Desarrollo BIO23/EM/007Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas CB06/05/0076Spanish Ministry of Science and Innovation PID2019-109724RB-I00Spanish Ministry of Science and Innovation PID2022-138276OB-I00
6 · The paper itself

Abstract

Interferon regulatory factor 5 (IRF5) is a transcription factor that plays a role in orchestrating innate immune responses, particularly in response to viral infections. Notably, IRF5 has been identified as a microglia risk gene linked to multiple sclerosis (MS), but its specific role in MS pathogenesis remains unclear. Through the use of Irf5

Indexed as

CholesterolDemyelinating DiseasesInterferon Regulatory FactorsMicrogliaMyelin SheathAnimalsEncephalomyelitis, Autoimmune, ExperimentalFemaleLipid MetabolismMiceMice, Inbred C57BLMice, KnockoutMultiple SclerosisOligodendrogliaPhagocytosisCholesterolInterferon Regulatory FactorsIrf5 protein, mouseDemyelinationIRF5Lipid homeostasisMicrogliaMultiple sclerosisRemyelination

Identifiers

PMID40137979
PMCPMC11947375

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.